Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review
Managing the Economic Challenges in the Treatment of Heart Failure
Highly Selective Inhibition of Myosin Motors Provides the Basis of Potential Therapeutic Application
Smooth Muscle Myosin Inhibition: A Novel Therapeutic Approach for Pulmonary Hypertension
Inhibition of Smooth Muscle Myosin as a Novel Therapeutic Target for Hypertension
The Direct Smooth Muscle Myosin Inhibitor, CK-2125927, Represents a Novel Therapeutic Mechanism of Bronchodilation
The Direct Smooth Muscle Myosin Inhibitor, CK-2018571, Represents a Novel Therapeutic Mechanism for Bronchodilation
The Small Molecule Smooth Muscle Myosin Inhibitor, CK-2018571, Selectively Inhibits ATP Hydrolysis and Relaxes Smooth Muscle in vitro
Inhibition of Smooth Muscle Myosin, a Novel Therapeutic Approach for Pulmonary Hypertension
A Direct Inhibitor of Smooth Muscle Myosin as a Novel Therapeutic Approach for the Treatment of Systemic Hypertension.